Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH plus ) Chronic Myeloid Leukemia (CML) or PH plus Acute Lymphoblastic Leukemia (ALL): a Pharmacokinetic Study

被引：0
|
作者：
Hijiya, Nobuko [1 ]
Zwaan, C. Michel [1 ]
Rizzari, Carmelo [1 ]
Foa, Roberto [1 ]
Abbink, Floor [1 ]
Lancaster, Donna [1 ]
Landman-Parker, Judith [1 ]
Millot, Frederic [1 ]
Moppett, John [1 ]
Nelken, Brigitte [1 ]
Ducassou, Stephane [1 ]
Putti, Maria Caterina [1 ]
Tian, Xianbin [1 ]
Sinclair, Karen [1 ]
Santanastasio, Helene [1 ]
Buchbinder, Aby [1 ]
Kearns, Pamela [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [1] Dasatinib population pharmacokinetics in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (ph plus all)
    Dai, Guowei
    Roy, Amit
    Mandava, Mohan
    Blackwood-Chirchir, Anne
    Luo, Roger
    Wu, Chiyuan
    Pfister, Marc
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1085 - 1085
  • [2] Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Robin
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 812 - 820
  • [3] SAFETY AND TOLERABILITY OF DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL): POOLED ANALYSIS OF OVER 2400 PATIENTS
    Saglio, G.
    le Coutre, P.
    Cortes, J.
    Mayer, J.
    Rowlings, P.
    Subar, M.
    Preston, J.
    Shah, N.
    HAEMATOLOGICA, 2014, 99 : 329 - 329
  • [4] Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Patel, Jai N.
    Lopes, Karine Eboli
    Druhan, Lawrence J.
    Zeng, Hang
    Beam, Travis
    Moore, Donald C.
    Salem, Ahmed
    Hamadeh, Issam
    Savage, Quanisha
    Chojecki, Aleksander L.
    Ai, Jing
    Knight, Thomas G.
    Ragon, Brittany Knick
    Shah, Nilay A.
    Sanikommu, Srinivasa Reddy
    Steuerwald, Nury M.
    Smith, Mathew
    Hamilton, Alicia
    Rangavajhula, Keerthana
    Bell, Ariel
    Drummond, Kendra
    Symanowski, James T.
    Grunwald, Michael R.
    BLOOD, 2022, 140 : 11530 - 11531
  • [5] Nilotinib in patients (pts) with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) who are resistant or intolerant to imatinib
    Ottmann, Oliver G.
    Larson, Richard A.
    Kantarjian, Hagop M.
    le Coutre, Philipp
    Baccarani, Michele
    Haque, Ariful
    Gallagher, Neil
    Giles, Francis
    BLOOD, 2007, 110 (11) : 828A - 828A
  • [6] Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Jabbour, Elias
    Koller, Paul B.
    Oehler, Vivian G.
    Jamy, Omer H.
    Mukherjee, Sudipto
    Hunter, Anthony M.
    Baer, Maria R.
    Beck, Joseph T.
    Chen, Zi
    Guo, Huanshan
    Fu, Lei
    Men, Lichuang
    Wang, Hengbang
    Yang, Dajun
    Zhai, Yifan
    Kantarjian, Hagop
    Jiang, Lixin
    Wang, Cunlin
    BLOOD, 2022, 140
  • [7] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Konopleva, Marina Y.
    Khouri, Rita
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Nunez, Cesar
    Kadia, Tapan M.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [8] Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL): Data from a Nationwide Belgian Registry
    Devos, Timothy
    Havelange, Violaine
    Theunissen, Koen
    Meers, Stef
    Benghiat, Fleur Samantha
    Gadisseur, Alain
    Vanstraelen, Gaetan
    Andre, Marc
    Bailly, Benjamin
    Granacher, Nikki
    Lewalle, Philippe
    De Becker, Ann
    Van Eygen, Koen
    Lejeune, Marie
    Deeren, Dries
    Nifosi, Gianfilippo
    Triffet, Agnes
    Vrelust, Inge
    Bekaert, Julie
    Beck, Michael
    Selleslag, Dominik
    BLOOD, 2019, 134
  • [9] Multivariate Analyses of the Clinical and Molecular Parameters Associated with Efficacy and Safety in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Treated with Ponatinib in the PACE Trial
    Mauro, Michael J.
    Cortes, Jorge E.
    Kim, Dong-Wook
    Pinilla-Ibarz, Javier
    le Coutre, Philipp
    Paquette, Ronald
    Chuah, Charles
    Nicolini, Franck E.
    Apperley, Jane
    Khoury, H. Jean
    Talpaz, Moshe
    DiPersio, John F.
    DeAngelo, Daniel J.
    Abruzzese, Elisabetta
    Rea, Delphine
    Baccarani, Michele
    Muller, Martin C.
    Gambacorti-Passerini, Carlo
    Wong, Stephane
    Dorer, David J.
    Knickerbocker, Ronald Keith
    Rivera, Victor M.
    Clackson, Tim
    Turner, Christopher D.
    Haluska, Frank G.
    Guilhot, Francois
    Deininger, Michael W.
    Hochhaus, Andreas
    Hughes, Timothy
    Goldman, John M.
    Shah, Neil
    Kantarjian, Hagop M.
    BLOOD, 2012, 120 (21)
  • [10] Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia
    Hijiya, Nobuko
    Maschan, Alexey
    Rizzari, Carmelo
    Shimada, Hiroyuki
    Dufour, Carlo
    Goto, Hiroaki
    Kang, Hyoung Jin
    Guinipero, Terri
    Karakas, Zeynep
    Bautista, Francisco
    Ducassou, Stephane
    Yoo, Keon Hee
    Zwaan, Christian Michel
    Millot, Frederic
    Aimone, Paola
    Allepuz, Alex
    Quenet, Sara
    Hourcade-Potelleret, Florence
    Hertle, Sabine
    Sosothikul, Darintr
    BLOOD, 2019, 134 (23) : 2036 - 2045
12345